Page last updated: 2024-08-18

cyclohexanol and Esophageal Diseases

cyclohexanol has been researched along with Esophageal Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, JH; Kim, JJ; Kim, S; Lee, H; Lee, JH; Min, BH; Rhee, JC; Rhee, PL; Son, HJ; Suh, YJ1
Tutuian, R1

Trials

1 trial(s) available for cyclohexanol and Esophageal Diseases

ArticleYear
Efficacy of venlafaxine for symptomatic relief in young adult patients with functional chest pain: a randomized, double-blind, placebo-controlled, crossover trial.
    The American journal of gastroenterology, 2010, Volume: 105, Issue:7

    Topics: Adult; Anxiety; Chest Pain; Chi-Square Distribution; Cross-Over Studies; Cyclohexanols; Delayed-Action Preparations; Depression; Double-Blind Method; Esophageal Diseases; Esophageal pH Monitoring; Female; Humans; Male; Manometry; Placebos; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Statistics, Nonparametric; Surveys and Questionnaires; Treatment Outcome; Venlafaxine Hydrochloride

2010

Other Studies

1 other study(ies) available for cyclohexanol and Esophageal Diseases

ArticleYear
Editorial: venlafaxine for functional chest pain: hope or hype?
    The American journal of gastroenterology, 2010, Volume: 105, Issue:7

    Topics: Adult; Chest Pain; Cross-Over Studies; Cyclohexanols; Double-Blind Method; Esophageal Diseases; Esophageal pH Monitoring; Female; Humans; Male; Manometry; Randomized Controlled Trials as Topic; Risk Factors; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Sex Factors; Venlafaxine Hydrochloride

2010